
Publication|Articles|May 8, 2025
- Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists
Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists
Advertisement
This program is made possible by an independent grant from Boehringer Ingleheim Pharmaceuticals, Inc. and Eli Lilly and Company.
This article summarizes collaborative strategies used by pharmacists to enhance chronic kidney disease screening, patient identification, and integration into diagnostic workflows, based on recommendations gleaned from roundtables of expert pharmacist stakeholders representing 23 different institutions.
View Issue
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
Long-Lived Monocyte-Derived Cells Found to Support Lasting Lung Immunity Against Influenza
4
What Pharmacists Should Know About the Ifosfamide Shortage
5





































































































